Question from Deputy Ken O'Flynn - PQ 32472-26
Deputy O'Flynn asked about the recommended and maximum caseload threshold per SCAN nurse. Read the HSE response.
- Published date:
- :
Corporate publications
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Showing 1411 to 1420 of 7651 results
Question from Deputy Ken O'Flynn - PQ 32471-26
Deputy O'Flynn asked about the highest and lowest caseload recorded per SCAN post in 2025. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 32470-26
Deputy O'Flynn asked about the national average caseload per Suicide Crisis Assessment Nurse (SCAN) post in 2025. Red the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 32351-26
Deputy O'Flynn asked about the number of patients accessing obesity treatment services. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 32352-26
Deputy O'Flynn asked about the clinical guidelines in place governing access to pharmacological treatments for obesity. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 32353-26
Deputy O'Flynn asked if any any assessment has been conducted on waiting times for access obesity services. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O’Flynn - PQ 32688-26
Deputy O'Flynn asked about the number of applicants for positions at South Infirmary Victoria University Hospital. Read the HSE response.
- Published date:
- :
Question from Deputy Pádraig O'Sullivan - PQ 33050-26
Deputy O'Sullivan asked about the staffing in each Children's Disability Network Team in Cork. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 32354-26
Deputy O'Flynn asked about the reimbursement of new pharmacological treatments for obesity. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O’Flynn - PQ 32775-26
Deputy O'Flynn asked about international reimbursement or access decisions in respect of omaveloxolone (Skyclarys). Read the HSE response.
- Published date:
- :